vs

Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and REPUBLIC BANCORP INC (RBCAA). Click either name above to swap in a different company.

REPUBLIC BANCORP INC is the larger business by last-quarter revenue ($94.3M vs $77.6M, roughly 1.2× Bioceres Crop Solutions Corp.). REPUBLIC BANCORP INC runs the higher net margin — 24.2% vs -9.6%, a 33.8% gap on every dollar of revenue. On growth, REPUBLIC BANCORP INC posted the faster year-over-year revenue change (5.3% vs -16.8%). Over the past eight quarters, Bioceres Crop Solutions Corp.'s revenue compounded faster (-8.4% CAGR vs -11.5%).

Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.

Republic Bancorp Inc. (Kentucky) is a U.S. regional banking holding company that provides a full range of retail and commercial banking services, including personal deposit accounts, consumer loans, business financing, mortgage products, and wealth management solutions. It mainly serves individual consumers and small to medium-sized enterprises in Kentucky and adjacent U.S. states.

BIOX vs RBCAA — Head-to-Head

Bigger by revenue
RBCAA
RBCAA
1.2× larger
RBCAA
$94.3M
$77.6M
BIOX
Growing faster (revenue YoY)
RBCAA
RBCAA
+22.1% gap
RBCAA
5.3%
-16.8%
BIOX
Higher net margin
RBCAA
RBCAA
33.8% more per $
RBCAA
24.2%
-9.6%
BIOX
Faster 2-yr revenue CAGR
BIOX
BIOX
Annualised
BIOX
-8.4%
-11.5%
RBCAA

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BIOX
BIOX
RBCAA
RBCAA
Revenue
$77.6M
$94.3M
Net Profit
$-7.4M
$22.8M
Gross Margin
46.8%
Operating Margin
9.3%
29.3%
Net Margin
-9.6%
24.2%
Revenue YoY
-16.8%
5.3%
Net Profit YoY
-20.2%
20.0%
EPS (diluted)
$-0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIOX
BIOX
RBCAA
RBCAA
Q4 25
$94.3M
Q3 25
$77.6M
$93.5M
Q2 25
$93.8M
Q1 25
$60.6M
$135.8M
Q4 24
$98.8M
$89.5M
Q3 24
$93.3M
$88.1M
Q2 24
$86.9M
Q1 24
$84.0M
$120.3M
Net Profit
BIOX
BIOX
RBCAA
RBCAA
Q4 25
$22.8M
Q3 25
$-7.4M
$29.7M
Q2 25
$31.5M
Q1 25
$-1.6M
$47.3M
Q4 24
$605.2K
$19.0M
Q3 24
$-6.2M
$26.5M
Q2 24
$25.2M
Q1 24
$9.8M
$30.6M
Gross Margin
BIOX
BIOX
RBCAA
RBCAA
Q4 25
Q3 25
46.8%
Q2 25
Q1 25
39.4%
Q4 24
42.0%
Q3 24
40.2%
Q2 24
Q1 24
50.8%
Operating Margin
BIOX
BIOX
RBCAA
RBCAA
Q4 25
29.3%
Q3 25
9.3%
40.4%
Q2 25
43.0%
Q1 25
1.5%
44.1%
Q4 24
14.5%
25.8%
Q3 24
2.5%
38.4%
Q2 24
37.0%
Q1 24
15.7%
32.2%
Net Margin
BIOX
BIOX
RBCAA
RBCAA
Q4 25
24.2%
Q3 25
-9.6%
31.8%
Q2 25
33.5%
Q1 25
-2.6%
34.8%
Q4 24
0.6%
21.2%
Q3 24
-6.6%
30.1%
Q2 24
29.0%
Q1 24
11.6%
25.4%
EPS (diluted)
BIOX
BIOX
RBCAA
RBCAA
Q4 25
Q3 25
$-0.12
Q2 25
Q1 25
$-0.02
Q4 24
$0.00
Q3 24
$-0.10
Q2 24
Q1 24
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIOX
BIOX
RBCAA
RBCAA
Cash + ST InvestmentsLiquidity on hand
$15.5M
$220.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$288.3M
$1.1B
Total Assets
$734.9M
$7.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIOX
BIOX
RBCAA
RBCAA
Q4 25
$220.0M
Q3 25
$15.5M
$484.2M
Q2 25
$484.8M
Q1 25
$38.5M
$793.0M
Q4 24
$29.2M
$432.2M
Q3 24
$32.3M
$530.9M
Q2 24
$400.1M
Q1 24
$16.4M
$546.4M
Stockholders' Equity
BIOX
BIOX
RBCAA
RBCAA
Q4 25
$1.1B
Q3 25
$288.3M
$1.1B
Q2 25
$1.1B
Q1 25
$345.0M
$1.0B
Q4 24
$346.3M
$992.0M
Q3 24
$346.0M
$979.7M
Q2 24
$955.4M
Q1 24
$348.5M
$935.6M
Total Assets
BIOX
BIOX
RBCAA
RBCAA
Q4 25
$7.0B
Q3 25
$734.9M
$7.0B
Q2 25
$7.0B
Q1 25
$798.2M
$7.1B
Q4 24
$835.2M
$6.8B
Q3 24
$827.3M
$6.7B
Q2 24
$6.6B
Q1 24
$836.1M
$6.9B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIOX
BIOX
RBCAA
RBCAA
Operating Cash FlowLast quarter
$14.4M
$168.2M
Free Cash FlowOCF − Capex
$161.1M
FCF MarginFCF / Revenue
170.9%
Capex IntensityCapex / Revenue
7.5%
Cash ConversionOCF / Net Profit
7.37×
TTM Free Cash FlowTrailing 4 quarters
$288.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIOX
BIOX
RBCAA
RBCAA
Q4 25
$168.2M
Q3 25
$14.4M
$33.3M
Q2 25
$8.4M
Q1 25
$23.3M
$93.2M
Q4 24
$-5.4M
$149.0M
Q3 24
$5.2M
$51.3M
Q2 24
$4.0M
Q1 24
$-17.4M
$71.2M
Free Cash Flow
BIOX
BIOX
RBCAA
RBCAA
Q4 25
$161.1M
Q3 25
$30.8M
Q2 25
$5.2M
Q1 25
$91.6M
Q4 24
$143.2M
Q3 24
$49.8M
Q2 24
$2.7M
Q1 24
$69.1M
FCF Margin
BIOX
BIOX
RBCAA
RBCAA
Q4 25
170.9%
Q3 25
32.9%
Q2 25
5.5%
Q1 25
67.4%
Q4 24
160.0%
Q3 24
56.5%
Q2 24
3.1%
Q1 24
57.5%
Capex Intensity
BIOX
BIOX
RBCAA
RBCAA
Q4 25
7.5%
Q3 25
2.6%
Q2 25
3.5%
Q1 25
1.2%
Q4 24
6.5%
Q3 24
1.7%
Q2 24
1.5%
Q1 24
1.7%
Cash Conversion
BIOX
BIOX
RBCAA
RBCAA
Q4 25
7.37×
Q3 25
1.12×
Q2 25
0.27×
Q1 25
1.97×
Q4 24
-8.85×
7.84×
Q3 24
1.93×
Q2 24
0.16×
Q1 24
-1.78×
2.33×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons